Navigation Links
Weight Control for Obese Diabetics

According to a report in Archives of Internal Medicine ,a plate and cereal bowl with markers for proper portion sizes appear to help obese patients with diabetes lose weight and decrease their use of glucose-controlling medications.

Between 1960 and 2000, the proportion of U.S. adults who were obese increased from 13.4 percent to 30.9 percent, according to background information in the article. Most cases of type 2 diabetes can be attributed directly to obesity.

Restricting calories has been shown to improve blood sugar control in diabetics, partially by contributing to weight loss. The increasing prevalence of obesity is paralleled by increasing portion sizes in the marketplace, the authors write. Portion sizes are an important determinant of energy intake; the number of calories ingested by subjects at a meal has been directly correlated with the serving size offered.

Sue D. Pedersen, M.D., F.R.C.P.C., and colleagues at the University of Calgary, Alberta, Canada, conducted a six-month controlled trial of commercially available portion control plates and bowls in 2004.

The plates were divided into sections for carbohydrates, proteins, cheese and sauce, with the rest left open for vegetables. The sections approximately totaled an 800-calorie meal for men and a 650-calorie meal for women.

The cereal bowl is designed to allow a 200-calorie meal of cereal and milk. Half of 130 obese patients with diabetes (average age 56) were randomly assigned to use the plate for their largest meal and the bowl when they ate cereal for breakfast. The other half of the participants received usual care, which consisted of dietary assessment and teaching by dieticians.

At the end of the six-month follow-up, 122 patients remained in the study. Individuals using the portion-control dishes lost an average of 1.8 percent of their body weight, while those receiving usual care lost an average of 0.1 percent. '"/>




Page: 1 2

Related medicine news :

1. Lose Weight With New Wonder Slimming FDA approved Prescription Drug
2. Weight-Loss Drinks Can Make You Gassy
3. Smoking Linked To Low Infant Birth Weight
4. Weight gain following smoking cessation not linked to Leptin
5. Helping Kids Attain a Healthy Weight
6. Weight-loss Products Dangerous
7. Weight and Blood Pressure
8. Low Birth Weight infants could have Problems in the Future
9. Excess Weight Can Affect Individuals as They Age
10. Low-Fat, High-Carb Diet Equally Effective In Weight Loss
11. Weight Gain Found To Increase The Risk Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Weight Control for Obese Diabetics

(Date:10/6/2008)... Snacks, drinks sold not helping fight against chi...ONDAY, Oct. 6 (HealthDay News) -- Three-quarters o...s and sugared drinks are sold, a new study finds. ...ing machines in most middle schools, and "that tho...st choices," said study author Amy Virus, a regist...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire-FirstCall/ -- V...he development, manufacturing and sales of,product...peripheral artery,disease, today announced the rel...n California,s Rancho Cordova to San Diego. The ne...Valley area of San Diego and now,houses corporate ...
(Date:10/6/2008)... MONTEREY, Calif., Oct. 6 /PRNewswire/ -- Toda... System using eFlow Technology that uses single,do...lizer system. By,creating a proprietary, unit-dose..., the Closed System using eFlow Technology meets a...ng medication in the delivery device,simplifying ...
(Date:10/6/2008)... SEATTLE, Oct. 6 /PRNewswire/ -- A special sup...t time details guidelines for low- and,middle-inco...o detect and,treat the most common disease among w...east Health and Cancer Control -,Implementation" d...HGI),outlines a tiered system of resource allocati...
Breaking Medicine News(10 mins):Health News:Vending Machines Found in Most Middle Schools 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 2Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 3Health News:Volcano Corporation Announces the Relocation of Corporate Headquarters to San Diego 4Health News:PARI Pharma Unveils Closed System Using eFlow Technology at Medical Plastics Conference 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 2Health News:International Implementation of Breast Health Guidelines for Developing Countries Published by Cancer 3
...ting the millions of sufferers of HIV and AIDS may...nting the spread of this deadly disease// cannot b...ive it. That was the message during a "stock-taki...based Family Health International (FHI) leaders th...
...x-year-old girl died and five children were taken ...tamin A at their government school here.// The me...nutrition programme aimed at preventing blindness....o seven, are from the government-run primary schoo...
...naecological society has demanded a ban on the ill... infertility clinics across India// . The Federat...ndia (FOGSI) has said the large-scale direct sale ...sts and checks by sperm banks, was a serious matte...
...productive medicine specialist at the University a...e the fertility of tobacco smokers// who have low ...e sperm from male smokers were washed with a synth...cubation, there was a doubling in the fertilizing ...
Other Medicine News:Health News:'Prevention, Cultural Changes Must Lead AIDS Battle' 2Health News:New Compound May Improve Fertility in Smokers 2Health News:New Compound May Improve Fertility in Smokers 3
(Date:10/6/2008)...ct - Company,s Bioabsorbable Stent - Also,Slated f...- Data from multiple clinical trials ...,s Genous Bio-engineered R,stent, will be presente...erapeutics symposium, TCT 2008, in Washington, D.C...c Medical Center in,Amsterdam will provide a Genou...
(Date:10/3/2008)...wire-FirstCall/ -- Amsterdam Molecular,Therapeutic...gene therapy,announced today that it intends to i...orization Application (MAA) for Glybera(R) for Lip...ilitating and potentially lethal,disease., The da...ies (22,patients in total) demonstrate that Glyber...
(Date:10/2/2008)...sults of Rosetta Genomics, microRNA-based,Test, mi...From non Squamous non Small Cell Lung Cancer,...the miRview(TM) Technology First Approved for Clin...plexity Molecular Pathology Lab ...pecting to Launch miRview(TM) Squamous Later This ...
(Date:10/2/2008)...wire/ -- Athera Biotechnologies AB and Dyax,Corp. ...ered into a,collaboration to discover and to devel...tment of cardiovascular inflammatory diseases., T... work by Athera,scientific founders, Professors Fr.... The research links naturally occurring antibodie...
Breaking Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 2AMT Intends to Incorporate Additional Data to its Marketing Authorization Dossier for Glybera(R) 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 2Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 3Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 4Johns Hopkins University Researchers to Clinically Assess Rosetta Genomics' miRview(TM) Squamous Assay 5Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 3Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 4National Long Term Care Leaders to Release New Data Discuss Negative National Economic Jobs Impact 18955 1AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 1AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 2AutoImmune Inc Reports 2008 First Quarter Financial Results 18952 3Web Site Helps Patients Prepare for Hospital Stay 18948 1Web Site Helps Patients Prepare for Hospital Stay 18948 2Web Site Helps Patients Prepare for Hospital Stay 18948 3Development of new techniques to understand marble quality and durability 3248 1Development of new techniques to understand marble quality and durability 3248 2
...O, June 18, 2007 /PRNewswire-FirstCall/ -- Vical,I...ensee, AnGes MG,Inc. reported positive results fo... subjects to complete a Phase 3 trial of an,angiog...y,technology. Based on the findings that the prima...d with statistical,significance and that there wer...
...Italy, June 15 /CNW/ - Today AMADEO, one of the,fi...f two,angiotensin receptor blockers in hypertensi...ed at the European Society,of Hypertension, Milan...an reduces proteinuria to a significantly greater ...he results, Prof. Ellen Burgess, Foothills Hospita...
Other Medicine Technology:Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 2Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 3Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 4Vical Licensee AnGes MG Announces Positive Results of Phase 3,Angiogenesis Trial in Japan 5New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements.
VICTOR2 V measures prompt fluorescence, fluorescence polarization, luminescence, time-resolved fluorescence and absorbance. This model includes high density TRF (for 1536-well plates), temperature
This a new dedicated VICTOR2 model for fluorescence and luminescence detection with stacker and robotic loading.
The basic modular version of the VICTOR2 multilabel counter for fluorescence, luminescence and absorption measurements, with the stacker and the robotic loading configuration.
Medicine Products: